| 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]-3-fluorophenoxy]-1-oxido-N-(trideuteriomethyl)pyridin-1-ium-2-carboxamide |
4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]-3-fluorophenoxy]-1-oxido-N-(trideuteriomethyl)pyridin-1-ium-2-carboxamide |
1333489-03-4 |
| 4’-Azido-3’-O-benzoyl-5’-O-(m-chlorobenzoyl)-2’-deoxy-2’-fluoro-beta-D-arabinouridine |
4’-Azido-3’-O-benzoyl-5’-O-(m-chlorobenzoyl)-2’-deoxy-2’-fluoro-beta-D-arabinouridine |
1333126-30-9 |
| Apalutamide Acid Impurity |
Apalutamide Acid Impurity |
1332391-04-4 |
| Ozagrel-015 |
奥扎格雷标准品015 |
1332370-00-9 |
| 2,2'-[4-(2-Methylpropoxy)-1,3-phenylene]bis[4-Methyl-5-thiazolecarboxylic Acid 5,5'-DiMethyl Ester |
非布司他杂质C |
1330632-47-7 |
| N-[4-nitro-2-(2,3,4,5,6-pentadeuteriophenoxy)phenyl]methanesulfonamide |
尼美舒利杂质 |
1330180-22-7 |
| Enoxacin-(piperazinyl-d8) hydrate |
Enoxacin-(piperazinyl-d8) hydrate |
1329642-60-5 |
| Acetoxy-Lysylpyridinoline |
Acetoxy-Lysylpyridinoline |
1321573-23-2 |
| Lacosamide Impurity 2 |
Lacosamide Impurity 2 |
1325220-60-7 |
| Tofacitinib Impurity 38 |
Tofacitinib Impurity 38 |
1325182-06-6 |
| Icotinib Impurity 6 |
Icotinib Impurity 6 |
1318600-03-1 |
| Icotinib Impurity 4 |
Icotinib Impurity 4 |
1318599-96-0 |
| Clopidogrel Impurity 72 |
Clopidogrel Impurity 72 |
1314028-89-1 |
| 阿维A杂质Ⅲ(13-乙基阿维A) |
阿维A杂质Ⅲ(13-乙基阿维A) |
1313741-10-4 |
| Ambrisentan Impurity E |
安立生坦杂质E |
1312092-82-2 |
| ABT-494 ENANTIOMER |
乌帕替尼杂质18 |
1310726-59-0 |
| (phenoxycarbonyl)-D-valine |
利托那韦杂质59 |
1310695-86-3 |
| Cariprazine-d6 |
卡利拉嗪-D6 |
1308278-67-2 |
| Pyrimidine, 4-bromo-6-(1-bromoethyl)-5-fluoro- |
Pyrimidine, 4-bromo-6-(1-bromoethyl)-5-fluoro- |
1307315-02-1 |
| Ceftazidime Oxide Impurity |
Ceftazidime Oxide Impurity |
1301254-48-7 |
